HOLX Hologic Inc

Price (delayed)

$75.83

Market cap

$19.22B

P/E Ratio

9.64

Dividend/share

N/A

EPS

$7.87

Enterprise value

$21.54B

Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn ...

Highlights
The gross profit has soared by 152% YoY and by 6% from the previous quarter
HOLX's equity has surged by 72% year-on-year and by 2.2% since the previous quarter
Hologic's quick ratio has decreased by 38% QoQ but it has increased by 11% YoY
The company's debt rose by 13% QoQ but it fell by 5% YoY

Key stats

What are the main financial stats of HOLX
Market
Shares outstanding
253.49M
Market cap
$19.22B
Enterprise value
$21.54B
Valuations
Price to earnings (P/E)
9.64
Price to book (P/B)
5.01
Price to sales (P/S)
3.43
EV/EBIT
8.08
EV/EBITDA
7.06
EV/Sales
3.8
Earnings
Revenue
$5.66B
EBIT
$2.67B
EBITDA
$3.05B
Free cash flow
$2.13B
Per share
EPS
$7.87
Free cash flow per share
$8.3
Book value per share
$15.13
Revenue per share
$22.1
TBVPS
$13.76
Balance sheet
Total assets
$8.59B
Total liabilities
$4.71B
Debt
$3.14B
Equity
$3.88B
Working capital
$953.6M
Liquidity
Debt to equity
0.81
Current ratio
1.65
Quick ratio
1.21
Net debt/EBITDA
0.76
Margins
EBITDA margin
53.9%
Gross margin
68.9%
Net margin
36%
Operating margin
47%
Efficiency
Return on assets
26%
Return on equity
59.7%
Return on invested capital
59.6%
Return on capital employed
37.4%
Return on sales
47.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HOLX stock price

How has the Hologic stock price performed over time
Intraday
1.05%
1 week
6.01%
1 month
11.99%
1 year
8.67%
YTD
4.12%
QTD
13.65%

Financial performance

How have Hologic's revenue and profit performed over time
Revenue
$5.66B
Gross profit
$3.9B
Operating income
$2.66B
Net income
$2.04B
Gross margin
68.9%
Net margin
36%
The gross profit has soared by 152% YoY and by 6% from the previous quarter
The company's net margin has surged by 138% YoY
The revenue has soared by 72% YoY and by 6% from the previous quarter
Hologic's gross margin has increased by 47% YoY

Growth

What is Hologic's growth rate over time

Valuation

What is Hologic stock price valuation
P/E
9.64
P/B
5.01
P/S
3.43
EV/EBIT
8.08
EV/EBITDA
7.06
EV/Sales
3.8
The stock's price to earnings (P/E) is 19% less than its last 4 quarters average of 11.9
The EPS is up by 7% since the previous quarter
HOLX's equity has surged by 72% year-on-year and by 2.2% since the previous quarter
HOLX's price to book (P/B) is 5% lower than its last 4 quarters average of 5.3
The revenue has soared by 72% YoY and by 6% from the previous quarter
HOLX's price to sales (P/S) is 10% lower than its last 4 quarters average of 3.8 and 7% lower than its 5-year quarterly average of 3.7

Efficiency

How efficient is Hologic business performance
The ROE has soared by 162% YoY but it has contracted by 6% from the previous quarter
HOLX's return on invested capital is up by 5% since the previous quarter

Dividends

What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HOLX.

Financial health

How did Hologic financials performed over time
The total assets is 82% higher than the total liabilities
Hologic's quick ratio has decreased by 38% QoQ but it has increased by 11% YoY
Hologic's current ratio has decreased by 36% from the previous quarter but it has increased by 12% YoY
The company's debt is 19% lower than its equity
HOLX's equity has surged by 72% year-on-year and by 2.2% since the previous quarter
Hologic's debt to equity has decreased by 45% YoY but it has increased by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.